Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab

Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab

Abstract Background Although a recent randomized clinical trial has demonstrated that the objective response rate to nivolumab for metastatic gastric cancer was 11.2%, there was no patients confirmed complete response. Herein, we report on a case of liver metastasis arising from early gastric cancer...

Full description

Saved in:
Bibliographic Details
Main Authors: Tsutomu Namikawa, Nobuko Ishida, Sachi Tsuda, Kazune Fujisawa, Eri Munekage, Jun Iwabu, Masaya Munekage, Sunao Uemura, Shigehiro Tsujii, Hiromichi Maeda, Hiroyuki Kitagawa, Michiya Kobayashi, Kazuhiro Hanazaki
Format: Article
Language:English
Published: Japan Surgical Society 2018-07-01
Series:Surgical Case Reports
Subjects:
Gastric cancer
Nivolumab
Complete response
Chemotherapy
Biomarker
Online Access:http://link.springer.com/article/10.1186/s40792-018-0479-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://link.springer.com/article/10.1186/s40792-018-0479-3

Similar Items